Featured Research

from universities, journals, and other organizations

Another serious eye disease, uveitis, linked to smoking

Date:
March 18, 2010
Source:
American Academy of Ophthalmology
Summary:
Smoking is already a known risk factor for age-related macular degeneration, cataract and thyroid eye disease. Now, the first study to specifically examine the impact of smoking on uveitis-inflammation of the eye's middle layer of tissue-indicates that tobacco smoke likely plays a role in this serious eye disease, as well. In the United States about 10 percent of blindness is caused by uveitis.

Smoking is already a known risk factor for age-related macular degeneration, cataract and thyroid eye disease. Now, the first study to specifically examine the impact of smoking on uveitis-inflammation of the eye's middle layer of tissue-indicates that tobacco smoke likely plays a role in this serious eye disease, as well. In the United States about 10 percent of blindness is caused by uveitis.

Researchers led by Nisha Acharya, MD, analyzed medical records for smoking status and the type and cause of inflammation for all uveitis clinic patients seen at the University of California, San Francisco's F.I. Proctor Foundation between 2002 and 2009. Results for this patient group were compared with a matched control group and the data were adjusted for differences in age, race, gender, and median income. Smokers were 2.2 times more likely to have uveitis than those who had never smoked. Smoking correlated with higher risk of uveitis for all anatomical locations within the eye and for both infectious and non-infectious disease types. A particularly strong relationship was found between smoking and inflammatory central macular edema (swelling of the central area of the retina) in patients with certain types of uveitis.

"Cigarette smoke includes compounds that stimulate inflammation within the blood vessels, and this may contribute to immune system disruption and uveitis," Dr. Acharya said. If other research replicates the UCSF findings, uveitis risk would be another reason for healthcare providers to advise people to stop smoking.

If uveitis symptoms such as eye redness, blurred vision, pain and sensitivity to light occur, people should seek medical care right away. Uveitis can harm important structures like the iris in the front of the eye, and the retina, the light-sensitive tissue at the back of the eye where images are focused and relayed to the optic nerve. The condition can develop in people with systemic diseases such as multiple sclerosis or juvenile arthritis or be part of the body's response to an infection like herpes simplex or tuberculosis. Often, though, uveitis has no apparent cause.

This research is reported in the March issue of Ophthalmology, the journal of the American Academy of Ophthalmology.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Ophthalmology. "Another serious eye disease, uveitis, linked to smoking." ScienceDaily. ScienceDaily, 18 March 2010. <www.sciencedaily.com/releases/2010/03/100301135215.htm>.
American Academy of Ophthalmology. (2010, March 18). Another serious eye disease, uveitis, linked to smoking. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100301135215.htm
American Academy of Ophthalmology. "Another serious eye disease, uveitis, linked to smoking." ScienceDaily. www.sciencedaily.com/releases/2010/03/100301135215.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins